<DOC>
	<DOC>NCT03077620</DOC>
	<brief_summary>The purpose of this study is to change the concentration of amyloid-beta in human cerebrospinal fluid (CSF) by modification of sleep efficiency.</brief_summary>
	<brief_title>Sleep Quality and Amyloid-Beta Kinetics</brief_title>
	<detailed_description>The purpose of the study is to investigate whether or not increasing sleep efficiency will change the concentration of amyloid-beta in cerebrospinal fluid (CSF).</detailed_description>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Suvorexant</mesh_term>
	<criteria>Age 4565 years Any sex Any race/ethnicity MiniMental Status Examination score (MMSE) &gt;=27 Insomnia Severity Index &lt;8 Sleep efficiency measured by actigraphy to determine good sleeper or poor sleeper Cognitive impairment as determined by history of MMSE &lt; 27 Inability to speak or understand English BMI &gt;35 Any sleep disorders other than insomnia history of sleepdisordered breathing STOPBang score &gt; 2 History or reported symptoms suggestive of restless legs syndrome, narcolepsy or other sleep disorders Sleep schedule outside the range of bedtime 8PM12AM and wake time 4AM8AM Contraindication to lumbar catheter (anticoagulants; bleeding disorder; allergy to lidocaine or disinfectant; prior central nervous system or lower back surgery) Cardiovascular disease requiring medication except for controlled hypertension Stroke Hepatic or renal impairment Pulmonary disease Diabetes Neurologic or psychiatric disorder requiring medication Alcohol or tobacco use (PI discretion) Use of sedating medications Inability to get out of bed independently Abnormal movement of the nondominant arm (would affect actigraphy data in unpredictable ways) Abnormal physical examination Current pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>